New cellular and molecular immune pathways in ischemia/reperfusion injury.
about
Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in ratsDeconvoluting post-transplant immunity: cell subset-specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cellsLipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart.Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway.A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expressionReoxygenation of hypoxia-differentiated dentritic cells induces Th1 and Th17 cell differentiation.The innate immune system in allograft rejection and tolerance.Infliximab attenuates early myocardial dysfunction after resuscitation in a swine cardiac arrest model.Kidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre.KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.Soluble biglycan as a biomarker of inflammatory renal diseases.Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction.Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury.Wound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative Medicine.Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.The role of hyaluronan degradation products as innate alloimmune agonists.Cardiac function and the proinflammatory cytokine response after recovery from cardiac arrest in swine.The role of indoleamine 2,3 dioxygenase in beneficial effects of stem cells in hind limb ischemia reperfusion injury.Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxiaReverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation.Mannan-Binding Lectin Is Involved in the Protection against Renal Ischemia/Reperfusion Injury by Dietary Restriction.Toll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia.TLR4 activation mediates kidney ischemia/reperfusion injurySitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors.Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice.Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac TransplantSuramin decreases injury and improves regeneration of ethanol-induced steatotic partial liver graftsNon-heart beating organ donation: overview and future perspectives.Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney TransplantationIschemia-reperfusion and immediate T cell responsesIL-18 contributes to renal damage after ischemia-reperfusionHepatocytes produce TNF-α following hypoxia-reoxygenation and liver ischemia-reperfusion in a NADPH oxidase- and c-Src-dependent manner.Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal TransplantationIRF-1 promotes inflammation early after ischemic acute kidney injury.Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response.Lymphocytes and ischemia-reperfusion injury.Pathophysiology of the systemic inflammatory response after major accidental trauma.The protective effect of baicalin against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis.Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4.Toll-like receptor 4 knockout mice are protected from endothelial overactivation in the absence of Kupffer cells after total hepatic ischemia/reperfusion.
P2860
Q28728804-AF62DD89-3467-454F-A9C0-C2DB13662A05Q28748866-AC5D840C-EC82-405F-BEF2-E976952AE135Q33280256-0BA08F69-4505-4BC2-B77A-FFD7B3B1967EQ33285480-F1871490-3314-426D-AFA3-8CB594E6A5F8Q33514016-96AAAC63-B0A2-4DA3-B90C-2FAA901F4A56Q33625463-E2884837-6502-4E7C-ABB0-483BCC016308Q33732470-7AA1156D-B7DC-4077-A6DC-5E50308E9DACQ33753939-757C0C23-5646-4A25-B87D-AFE89CF39350Q33754902-A19788C0-5791-4255-A1CD-86F0923E22F2Q34017594-F613FCCF-1E0C-474A-A2B8-8D8783AF5861Q34160971-233A011A-3C4A-46E7-A245-FE39C7DA49A3Q34170356-2F4E3FD1-5D66-422F-82A4-68F7B8017E46Q34364207-805FDFF9-2B3F-4628-9C32-646261F9EE95Q34385682-1F5ACDE2-2BA6-45F7-9089-E07D5F16304AQ34508051-F0DAE86B-9010-4B0A-A7C4-6B285D6BC539Q34574846-24819A90-3144-4004-B713-F7E46D3A12C4Q34987232-74424C5A-6B2E-431B-9B16-28EE9DFF0BD1Q35154150-56DC1BC1-1AB0-4490-844C-8A89350097F2Q35169612-17A7623A-7D5C-4005-9DCB-C5C0DCDD060BQ35657838-39E30799-21C4-493B-A4DF-AF738468AB8DQ35773025-FF06D934-847D-4EBC-B624-096160BA2CA7Q35791682-AE52CE24-845F-4622-95F9-8DFF14AB750EQ35987574-F08021EC-8964-4C52-8863-EE0CDFFE26EBQ36063727-47D77D2F-15FD-4904-8828-23DCB5DEF513Q36146071-302F304C-C689-4A35-B111-ACFAE88E453FQ36302489-060DB4F8-5B9E-4E99-895F-4081A2C11322Q36573237-063513C5-F84C-4589-97A1-C94C7FD5523FQ36722485-4FB82D67-367C-427D-8632-6037D68B2C93Q36839878-F556F01B-86AC-4409-8E74-899343208E6CQ36973884-D5216B4C-D283-46CC-840D-8C7E391C7748Q36985801-2FA4E261-180C-4207-B009-3840F3F3F6DAQ37051544-A7C9F7FE-A211-460E-84BC-570E9FE3DAD7Q37200856-65CB53B2-2F99-4F3F-998B-031D1769C45EQ37259315-20D8838E-F03F-4446-AF59-CE4AFE8E3604Q37317375-CE937098-4426-448B-94C1-0D8798641F1FQ37332688-D07625D1-C854-4EB7-9B09-797392E02ECEQ37375163-16829576-AAB0-4FEF-9391-A3C250C03809Q37485525-D2FFC2AC-6C73-4F6D-80A1-F4CE7D09AE06Q37532531-785BB205-1378-4DE4-B5F6-6E11A1F42352Q37650587-E04D01FA-ECC0-42B1-829E-D577F8D25A26
P2860
New cellular and molecular immune pathways in ischemia/reperfusion injury.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
New cellular and molecular immune pathways in ischemia/reperfusion injury.
@ast
New cellular and molecular immune pathways in ischemia/reperfusion injury.
@en
type
label
New cellular and molecular immune pathways in ischemia/reperfusion injury.
@ast
New cellular and molecular immune pathways in ischemia/reperfusion injury.
@en
prefLabel
New cellular and molecular immune pathways in ischemia/reperfusion injury.
@ast
New cellular and molecular immune pathways in ischemia/reperfusion injury.
@en
P1476
New cellular and molecular immune pathways in ischemia/reperfusion injury.
@en
P2093
P304
P356
10.1111/J.1600-6143.2005.01228.X
P407
P577
2006-04-01T00:00:00Z